-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Stroke is the third leading cause of death and disability in the world, thus causing a huge economic and social burden.
About 84.
Mechanical treatment of intravascular thrombus benefit resection (MT), the success rate of recanalization can be increased to 70-80% endovascular mechanical thrombus benefit resection (MT), the success rate of recanalization can be increased to 70-80% thrombus
In order to ensure that LVO patients can get the most benefit from MT, various clinical attempts have been made, including pre-hospital screening and scheduling systems to minimize transportation time, emergency stroke severity scale and neuroimaging Scientific evaluation, timely selection of qualified patients, and improvement of reperfusion therapy and catheters to improve the complete reperfusion rate.
Screening
High systolic blood pressure after successful endovascular treatment of acute ischemic stroke is associated with an increased risk of intracranial hemorrhage.
High systolic blood pressure after successful endovascular treatment of acute ischemic stroke is associated with an increased risk of intracranial hemorrhage.
Researchers conducted a multi-center, open-label, randomized controlled trial in four academic hospital centers in France.
In both groups, the target systolic blood pressure must be reached within 1 hour after randomization and maintained by intravenous antihypertensive therapy for 24 hours.
A total of 162 patients were randomly assigned to the intensive target group and the standard target group.
65 (42%) of the 154 patients in the intensive target group and 68 (43%) of the 157 patients in the standard target group had intracranial hemorrhage observed in brain CT within 24-36 h after reperfusion, no significant statistics Learn the difference.
At the same time, there was no significant difference in hypotension events between the two groups.
In general, compared with the standard care systolic blood pressure target of 130-185 mmHg, the enhanced systolic blood pressure target of 100-129 mmHg after successful endovascular treatment does not reduce the rate of intracranial hemorrhage 24-36 h.
Compared with the standard care systolic blood pressure target of 130-185 mmHg, the enhanced systolic blood pressure target of 100-129 mmHg after successful endovascular treatment does not reduce the rate of intracranial hemorrhage 24-36 h.
references:
Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial.
Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial.
Leave a message here
